V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007849 | 280010423 | 0 | 42.75 | Curative (C) | 2017-01-14 | 2017-02-21 | WT SIOP 2002 01 post op VA | Y | Y | 280025627 | NOT MATCHED |
| 280007850 | 280005121 | 1.58 | 70.9 | Curative (C) | 2013-08-23 | 2013-08-23 | CARBOPLATIN + RT | N | Y | 280025630 | CARBOPLATIN + RT |
| 280007851 | 280008709 | 1.52 | 75.4 | Curative (C) | 2009-10-20 | 2014-10-09 | CARBOPLATIN + RT | N | Y | 280025632 | CARBOPLATIN + RT |
| 280007852 | 280008709 | 1.73 | 86 | Palliative (P) | 2016-09-08 | 2016-09-14 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280025632 | PACLITAXEL |
| 280007853 | 280008711 | 1.77 | 76 | Curative (C) | null | 2013-04-01 | Cetuximab + Radiotherapy Maint | 02 | Y | 280025638 | CETUXIMAB + RT |
| 280007854 | 280008711 | 0 | null | Curative (C) | 2016-08-22 | 2016-08-22 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280025638 | IVA |
| 280007855 | 280005128 | 1.7 | 81.6 | Palliative (P) | 2012-12-21 | 2013-04-08 | Doxorubicin 75mg/m2 | 02 | N | 280025643 | DOXORUBICIN |
| 280007856 | 280005128 | 1.78 | 93.8 | Curative (C) | null | 2014-04-06 | Cetuximab + Radiotherapy Maint | 02 | N | 280025643 | CETUXIMAB + RT |
| 280007857 | 280010427 | 0 | 60.4 | Curative (C) | 2012-12-17 | 2013-03-17 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | Y | 280025646 | IVA |
| 280007858 | 280008715 | 1.72 | 20.3 | Curative (C) | 2016-10-27 | 2016-11-27 | Cisplatin 7 day | N | null | 280025647 | CISPLATIN |
| 280007859 | 280005131 | 1.68 | 49.5 | null | 2015-02-06 | 2015-03-11 | Cisplatin 7 day | 02 | null | 280025652 | CISPLATIN |
| 280007860 | 280008717 | 0 | 65 | Curative (C) | 2014-11-07 | 2014-11-07 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280025655 | IVA |
| 280007861 | 280005134 | null | 98 | Curative (C) | 2015-10-30 | 2015-12-01 | Cisplatin 7 day | 02 | Y | 280025657 | CISPLATIN |
| 280007862 | 280005135 | 1.76 | 75 | Curative (C) | null | 2013-10-12 | Cisplatin | N | Y | 280025660 | CISPLATIN |
| 280007863 | 280005136 | 1.28 | null | Curative (C) | 2017-05-22 | 2017-06-13 | STS Rhabdo RMS 2005 Vin Cyclo | null | Y | 280025669 | RMS 2005 TRIAL |
| 280007864 | 280005137 | 1.6 | 40.7 | Curative (C) | 2016-10-01 | 2016-12-28 | Cisplatin 7 day | 02 | Y | 280025671 | CISPLATIN |
| 280007865 | 280005138 | 1.8 | null | Neo-adjuvant (N) | 2013-12-16 | 2014-01-15 | DOXORUBICIN | Y | N | 280025672 | DOXORUBICIN |
| 280007866 | 280010429 | 1.52 | 69.8 | Curative (C) | 2017-02-06 | 2017-02-20 | Cetuximab + Radiotherapy Maint | N | N | 280025673 | CETUXIMAB + RT |
| 280007867 | 280005139 | null | 47 | Curative (C) | 2016-06-05 | 2016-08-25 | Cisplatin | 02 | Y | 280025674 | CISPLATIN |
| 280007868 | 280008720 | 1.73 | 103.35 | Curative (C) | 2018-03-01 | 2018-03-19 | Cisplatin | N | Y | 280025677 | CISPLATIN |
| 280007869 | 280010430 | 1.71 | null | Adjuvant (A) | 2017-11-10 | 2017-11-19 | Cetuximab + Radiotherapy Maint | N | Y | 280025679 | CETUXIMAB + RT |
| 280007870 | 280011270 | 1.67 | 78.8 | Palliative (P) | 2016-12-18 | 2016-12-18 | Ifosfamide | 02 | N | 280025681 | IFOSFAMIDE |
| 280007871 | 280005140 | 1.7 | 33.2 | Adjuvant (A) | 2015-02-19 | 2015-02-20 | CARBOPLATIN + RT | 2 | Y | 280025684 | CARBOPLATIN + RT |
| 280007872 | 280008721 | 1.5 | 70.6 | Curative (C) | 2014-09-09 | 2014-09-21 | Cetuximab + Radiotherapy Maint | 02 | N | 280025689 | CETUXIMAB + RT |
| 280007873 | 280010431 | 1.62 | 85.2 | Adjuvant (A) | 2017-06-30 | 2017-08-19 | CARBOPLATIN + RT | N | Y | 280025695 | CARBOPLATIN + RT |
| 280007874 | 280010431 | 1.76 | null | Adjuvant (A) | 2017-12-15 | 2018-01-15 | Cisplatin 7 day | N | Y | 280025695 | CISPLATIN |
| 280007875 | 280010431 | 1.65 | 70.6 | Palliative (P) | 2018-06-14 | 2018-06-18 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280025695 | PACLITAXEL |
| 280007876 | 280005141 | 1.82 | null | Curative (C) | 2015-01-04 | 2015-01-16 | CARBOPLATIN + RT | 02 | N | 280025707 | CARBOPLATIN + RT |
| 280007877 | 280005142 | 1.76 | 85 | Neo-adjuvant (N) | 2014-04-28 | 2014-04-28 | DOXORUBICIN | 01 | N | 280025708 | DOXORUBICIN |
| 280007878 | 280005143 | 1.52 | 89 | Curative (C) | 2014-09-21 | 2014-11-03 | CARBOPLATIN + RT | N | null | 280025709 | CARBOPLATIN + RT |
| 280007879 | 280008722 | 1.76 | null | Curative (C) | 2014-09-20 | 2014-11-20 | CARBOPLATIN + RT | N | N | 280025711 | CARBOPLATIN + RT |
| 280007880 | 280008722 | 1.81 | 117 | Palliative (P) | 2014-09-01 | 2014-12-21 | Ifosfamide | 2 | N | 280025711 | IFOSFAMIDE |
| 280007881 | 280011272 | 1.7 | 116 | Curative (C) | 2015-10-14 | 2015-10-28 | CARBOPLATIN + RT | N | Y | 280025715 | CARBOPLATIN + RT |
| 280007882 | 280005144 | 1.8 | 66.1 | Curative (C) | 2015-07-01 | 2015-09-05 | Cetuximab + Radiotherapy Maint | 02 | Y | 280025716 | CETUXIMAB + RT |
| 280007883 | 280005144 | 1.56 | 60 | Neo-adjuvant (N) | 2015-06-03 | 2015-06-03 | DOXORUBICIN | N | N | 280025716 | DOXORUBICIN |
| 280007884 | 280005145 | null | 85 | Curative (C) | 2015-04-08 | 2015-10-11 | CARBOPLATIN + RT | N | Y | 280025720 | CARBOPLATIN + RT |
| 280007885 | 280005146 | 1.82 | 76.9 | Curative (C) | 2013-10-30 | 2014-01-05 | Cetuximab + Radiotherapy Maint | N | Y | 280025726 | CETUXIMAB + RT |
| 280007886 | 280005148 | 1.74 | 78 | Palliative (P) | 2017-03-04 | 2018-02-08 | Ifosfamide | N | N | 280025728 | IFOSFAMIDE |
| 280007887 | 280005151 | 0 | 93.75 | Curative (C) | 2014-12-19 | 2014-12-20 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | N | 280025728 | IVA |
| 280007888 | 280010433 | 1.81 | null | Curative (C) | 2014-02-21 | 2014-04-02 | CARBOPLATIN + RT | Y | Y | 280025737 | CARBOPLATIN + RT |
| 280007889 | 280011273 | 1.29 | 93.2 | Curative (C) | 2016-05-25 | 2016-08-24 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280025738 | IVA |
| 280007890 | 280005153 | 1.82 | 71 | Curative (C) | 2013-10-24 | 2014-01-20 | Cetuximab + Radiotherapy Maint | Y | Y | 280025740 | CETUXIMAB + RT |
| 280007891 | 280005156 | 1.7 | 61 | Curative (C) | 2016-09-01 | 2016-09-01 | Cisplatin 7 day | 02 | N | 280025742 | CISPLATIN |
| 280007892 | 280005157 | 1.83 | 91.9 | Neo-adjuvant (N) | 2016-05-20 | 2016-05-21 | Doxorubicin 75mg/m2 | N | N | 280025744 | DOXORUBICIN |
| 280007893 | 280005159 | null | null | Curative (C) | 2014-03-30 | 2014-04-26 | Cisplatin 7 day | N | Y | 280025746 | CISPLATIN |
| 280007894 | 280005159 | 1.52 | null | Curative (C) | 2017-04-03 | 2017-05-03 | IVA | N | null | 280025746 | IVA |
| 280007895 | 280005163 | 0 | 77.25 | Curative (C) | 2013-11-02 | 2014-11-18 | STS Rhabdomyosarcoma RMS 2005 VA | N | Y | 280025754 | RMS 2005 TRIAL |
| 280007896 | 280008729 | 1.8 | 66.1 | Curative (C) | 2016-12-09 | 2017-02-11 | Cisplatin | null | null | 280025755 | CISPLATIN |
| 280007897 | 280008730 | 1.7 | 89 | Curative (C) | 2014-10-25 | 2014-11-13 | Cetuximab + Radiotherapy Load | 02 | Y | 280025757 | CETUXIMAB + RT |
| 280007898 | 280005166 | 1.72 | 85.1 | Palliative (P) | 2014-11-25 | 2014-11-26 | DOXORUBICIN | N | N | 280025758 | DOXORUBICIN |